TriSalus Life Sciences to Host Virtual KOL Event on December 15, 2025 to Discuss TriNav Infusion System for Thyroid Disease Treatment.
ByAinvest
Thursday, Dec 4, 2025 4:03 pm ET1min read
TLSI--
TriSalus Life Sciences will host a virtual KOL event on December 15, 2025, to discuss the TriNav Infusion System for symptomatic thyroid disease. The event will feature Juan C. Camacho, MD, and will cover the unmet need, current treatment landscape, and the TriNav Infusion System's Pressure-Enabled Delivery for Thyroid Artery Embolization (PED-TAE) approach. A question and answer session will follow the presentations. The event aims to provide an overview of the TriNav Infusion System and its potential benefits for patients with symptomatic thyroid disease.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet